Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends.

[Guest guest]

http://www.ourstolenfuture.org/NewScience/human/cancer/2002/2002-1016cleggetal.h\

tm

 

 

Clegg, LX, EJ Feuer, DN Midthune, MP Fay and BF Hankey. 2002. Impact of

Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends.

Journal of the National Cancer Institute 94:1537–45.

 

 

 

Press coverage of this study

 

For years, optimistic messages coming from the National Cancer Institute and the

American Cancer Society had implied that after decades and billions of dollars

we were winning the war on cancer.

 

Mortality rates were on the way down because of better treatment, and even

incidence rates appeared to be leveling off, meaning that fewer people were

developing cancer than expected from past patterns. But this new analysis by

Clegg et al. reveals that for several of the most common cancers the incidence

statistics are far less rosy.

 

Incidence rates are still rising, not falling, and the trends for several

cancers are alarming. Thus while fewer people are dying, more people are having

their lives profoundly disrupted by cancer.

 

What did they do? Clegg et al. focused on the fact that it takes time for all

cancer cases to be reported to the national registry of cancer, NCI's SEER

(Surveillance, Epidemiology, and End Results), and for diagnosis corrections to

be incorporated. Previous estimates of cancer incidence rates had not accounted

for this delay adequately.

 

Some adjustment for delayed reporting was built explicitly into the system by

simply delaying the first reports of a year's data for two years, waiting beyond

the " deadline " (19 months after diagnosis) for cancer case reporting. But some

cases take much longer to report, sometimes many years. Periodically the cancer

incidence rates would be corrected to incorporate these delayed cases. Some of

the corrections also involved removal of cases after corrected diagnosis.

 

Clegg et al. developed a computer model that allowed them, based on past

experience, to predict the number of cases that are missed due to reporting

delay or removed because of diagnosis correction. To build the model, they

analyzed the history of reporting delays at nine cancer registries across the

US, focusing on melanoma, prostate cancer, female breast cancers, colorectal

cancer and lung/bronchus cancers. They then used the model to predict

missed/removed cases in the most recent SEER cancer incidence report, 1998

(published in 2000), and compared rates reported there with rates calculated by

summing known with predicted cases.

 

What did they find? Clegg et al. found that reporting delays for cancer cases

can last years. They calculate that it " would take 4–17 years for 99% or more of

the cancer cases to be reported, " and that the numbers in hand at the end of the

current reporting period, 2 years, amount to somewhere between 88% and 97% of

final cases counted.

 

These delays, in turn, introduce a bias into comparisons of recent vs

less-recent years. More cases were removed than added using the old approach,

and while this led to a better understanding of what had happened in earlier

years, it created a inappropriate base of comparison between older and recent

years: the old data set was complete, the more recent one was not. Any

comparison of time trends was then biased toward finding lower rates in the most

recent years, all other things being equal.

 

How big an effect did that bias create? The corrected estimates for female

breast cancer in whites in 1998, for example, is 4% higher than the uncorrected

calculation.

Cancer1998 AdjustmentFemale breast cancer+4%

Prostate cancer

(white males)

+12%Prostate cancer

(black males)+14%colorectal cancer +3%melanoma

(whites)

+14%lung cancer4%

These adjusments alter not only the assessment of cancer incidence in 1998, they

change the trend analysis. For example, prior to the adjustment, the trend

analysis of female breast cancer for the years 1987 to 1998 was flat: the trend

was not statistically distinguishable from no annual change. The adjustment,

however, revealed a statistically significant 0.6% annual increase in breast

cancer risk during recent years.

CancerAnnual Trend before Annual Trend afterFemale breast cancer

(white)

+0.4 ns +0.6%

Prostate cancer

(white males)

-0.1 ns +2.2% ns colorectal cancer

(white females)

+0.9% ns +2.8% ns melanoma

(white males)

-4.2% ns +4.1%lung cancer

(white females)0.5% ns 1.2%

[ " ns " indicates that the trend is statistically indistinguishable from no annual

change]

 

What does it mean? According to the authors, " our results suggest that ignoring

reporting delay and reporting error may result in the false impression of a

recent decline in cancer incidence when the apparent decline is, in fact, caused

by delayed reporting of the most recently diagnosed cases. "

 

This is important because the SEER data are key signposts used by the policy and

health community to gauge how well we are faring in the war against cancer. As

long as the incidence trends were perceived to be headed downward, people could

argue that we are winning. This new analysis suggests that we continue to lose,

and should heighten pressure to direct new resources toward understanding the

causes of cancer and toward prevention.

 

 

 

 

 

Gettingwell- / Vitamins, Herbs, Aminos, etc.

 

To , e-mail to: Gettingwell-

Or, go to our group site: Gettingwell

 

 

 

 

Mail Plus - Powerful. Affordable. Sign up now